-transparent.png){kind=logo}
Polymorphonuclear leucocyte chemotaxis was investigated in 6 patients with active dermatitis herpetiformis in the untreated state and when under control with Dapsone. Control studies were undertaken in 7 healthy volunteers. No significant difference in chemotaxis was demonstrated between the active, treated and control groups. Furthermore, when Dapsone in physiological concentrations was added separately in all three groups there was no additional effect on chemotaxis. These results clearly show that polymorphonuclear leucocytes from active untreated dermatitis herpetiformis have normal chemotactic activity compared with those from the same patients in the treated state and controls. Additional Dapsone did not alter these findings.
B W Millar, and
K J Macdonald, and
T M Macleod, and
E J Raffle
January 1981,
Acta dermato-venereologica,
B W Millar, and
K J Macdonald, and
T M Macleod, and
E J Raffle
June 1955,
Lancet (London, England),
B W Millar, and
K J Macdonald, and
T M Macleod, and
E J Raffle
April 1974,
The British journal of dermatology,
B W Millar, and
K J Macdonald, and
T M Macleod, and
E J Raffle
February 1981,
The British journal of dermatology,
B W Millar, and
K J Macdonald, and
T M Macleod, and
E J Raffle
January 1999,
Indian journal of dermatology, venereology and leprology,
B W Millar, and
K J Macdonald, and
T M Macleod, and
E J Raffle
June 1955,
Lancet (London, England),
B W Millar, and
K J Macdonald, and
T M Macleod, and
E J Raffle
January 1983,
The British journal of dermatology,
B W Millar, and
K J Macdonald, and
T M Macleod, and
E J Raffle
May 2017,
International journal of dermatology,
B W Millar, and
K J Macdonald, and
T M Macleod, and
E J Raffle
February 1977,
Lancet (London, England),
B W Millar, and
K J Macdonald, and
T M Macleod, and
E J Raffle
September 1980,
British journal of clinical pharmacology,
